PF-04136309 / Pfizer  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-04136309 / Pfizer
SR01: PF-04136309 for liver fibrosis

Temporarily Not Available
2
0
RoW
PF-04136309
Pfizer
Liver Fibrosis
 
 
NCT00689273: Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Completed
2
159
US, RoW
PF-04136309, Placebo
Pfizer
Osteoarthritis, Knee
11/08
11/08
NCT01226797: Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Terminated
2
24
RoW
Placebo, PF-04136309
Pfizer
Hepatitis C, Chronic
02/12
02/12
NCT02732938: Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Terminated
1b/2
22
US
PF-04136309, Nab-paclitaxel, Abraxane, Gemcitabine, Gemzar
Pfizer
Metastatic Pancreatic Ductal Adenocarcinoma
09/17
10/17

Download Options